Supporting the safe and efficient delivery of MPHO for patients
In our commitment to advancing patient safety and fostering healthcare innovation, ICCBBA is delighted to announce the opening of applications for the annual ICCBBA Enterprise Grant, beginning January 1, 2024. This opportunity is specifically aimed at transfusion and transplantation organizations in the field of Medical Products of Human Origin (MPHO).
🔍 Key information:
Application Period Opens: January 1, 2024
🌟What's in it for you:
Potentially gain access to grant support for your organization’s capacity-building initiatives.
Transform your organization's impact in the MPHO community.
💡 Coming soon:
Information Session in February: Learn more about the grant's objectives, and application process. Special Q&A included!
Dedicated Grant Page: Explore a user-friendly landing page dedicated to guiding you through the application process.
Information Blog: Stay informed with the latest details on the grant, application tips, and updates through our dedicated information blog.
Stay connected, stay informed, and stay inspired with ICCBBA.
Subscribe to our newsletter at: https://www.isbt128.org/newsletter
About ICCBBA:
ICCBBA is the international standards organization responsible for the management and development of the ISBT 128 Standard.
The acronym ISBT was originally derived from the important role played by the International Society of Blood Transfusion in the development of the standard. Today it expands as Information Standard for Blood and Transplant. The number 128 reflects the 128 characters of the ISO/IEC 646 7-bit character set.
The acronym ICCBBA is derived from the International Council for Commonality in Blood Banking Automation.
Author
Christina Salinas, Global Development Manager, ICCBBA